Active Ingredients: Salmeterol Xinafoate 25 mcg and Fluticasone Propionate 125 mcg per actuation
Manufacturer: Glenmark Pharmaceuticals Ltd.
Registration Number (MAL): MAL14055154AZ
Management of asthma in patients aged 12 years and older
Treatment of chronic obstructive pulmonary disease (COPD)
Prevention of bronchospasm and reduction of inflammation in the airways
Shake the inhaler well before each use
Hold the inhaler upright, exhale fully, place the mouthpiece between your teeth without biting, and form a good seal with your lips
Breathe in slowly and deeply through your mouth while pressing down firmly on the canister to release a dose
Hold your breath for 5–10 seconds, then breathe out gently
Repeat the above steps if a second dose is prescribed
Replace the cover after use
Rinse your mouth with water after each use to reduce the risk of oral thrush